InMed Pharmaceuticals Inc. (inm) Misses Q2 EPS by 364c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts inm Hot Sheet
Join SI Premium – FREE
InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.
For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Prospect Ridge closes $1.84M critical metals flow-through placement
- Okta to join S&P 500
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
